Matches in SemOpenAlex for { <https://semopenalex.org/work/W2368204729> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2368204729 endingPage "9" @default.
- W2368204729 startingPage "1" @default.
- W2368204729 abstract "Background : CHOP (cyclophosphamide, adriamycin, prednisolone, vincristine) regimen is still the standard therapy for non-Hodgkin's lymphoma, but its complete response rate & long-term survival rate are 4555% and 30%, respectively. New chemotherapy regimen will be required for enhancing response rate and duration of survival. We tried to treat non-Hodgkin's lymphoma with newly developing CHEP-OB (cyclophosphamide, adriamycin, etoposide, prednisolone, vincristine, bleomycin) combination chemotherapy which include etoposide, bleomycin in preexisting CHOP regimen. Methods: 51 patients with non-Hodgkin's lymphoma who admitted to Busan Paik Hospital lnje University between January 1996 and August 2002 were selected. They were treated with CHEP-OB combination chemotherapy given every 34 weeks for total 6 cycles. Results: Objective response was achieved in 82.4% of the patients. Complete response (CR) and partial response (PR) rates were 66.7% and 15.7%, respectively. CR rate was significantly lower in patients with T cell immmunophenotype. Five year overall (OS) and failure-free survival (FFS) rate were 61.9%, 54.7%, respectively. Multivariate analysis showed that sex, stage and attainment of CR were factors independently predictive for OS and that stage and attainment of CR were factors independently predictive for FFS. Major side effect was myelotoxicity. Conclusion: CHEP-OB combination chemotherapy might be useful as a treatment strategy in non-Hodgkin's lymphoma considering similar response and survival rate, lower toxicity when it is compared with 3rd generation combination chemotherapy. But more effective chemotherapeutic regimen needs to be explored." @default.
- W2368204729 created "2016-06-24" @default.
- W2368204729 creator A5029116843 @default.
- W2368204729 creator A5059560363 @default.
- W2368204729 creator A5075407973 @default.
- W2368204729 creator A5081839494 @default.
- W2368204729 creator A5089959567 @default.
- W2368204729 date "2004-01-01" @default.
- W2368204729 modified "2023-10-13" @default.
- W2368204729 title "The Effect of CHEP-OB Combination Chemotherapy in Non-Hodgkin's Lymphoma" @default.
- W2368204729 hasPublicationYear "2004" @default.
- W2368204729 type Work @default.
- W2368204729 sameAs 2368204729 @default.
- W2368204729 citedByCount "0" @default.
- W2368204729 crossrefType "journal-article" @default.
- W2368204729 hasAuthorship W2368204729A5029116843 @default.
- W2368204729 hasAuthorship W2368204729A5059560363 @default.
- W2368204729 hasAuthorship W2368204729A5075407973 @default.
- W2368204729 hasAuthorship W2368204729A5081839494 @default.
- W2368204729 hasAuthorship W2368204729A5089959567 @default.
- W2368204729 hasConcept C126322002 @default.
- W2368204729 hasConcept C141071460 @default.
- W2368204729 hasConcept C143998085 @default.
- W2368204729 hasConcept C2776232574 @default.
- W2368204729 hasConcept C2776694085 @default.
- W2368204729 hasConcept C2776715498 @default.
- W2368204729 hasConcept C2776755627 @default.
- W2368204729 hasConcept C2778119113 @default.
- W2368204729 hasConcept C2778336483 @default.
- W2368204729 hasConcept C2778476748 @default.
- W2368204729 hasConcept C2779338263 @default.
- W2368204729 hasConcept C2779429289 @default.
- W2368204729 hasConcept C2779725641 @default.
- W2368204729 hasConcept C2781413609 @default.
- W2368204729 hasConcept C3019864225 @default.
- W2368204729 hasConcept C71924100 @default.
- W2368204729 hasConcept C90924648 @default.
- W2368204729 hasConceptScore W2368204729C126322002 @default.
- W2368204729 hasConceptScore W2368204729C141071460 @default.
- W2368204729 hasConceptScore W2368204729C143998085 @default.
- W2368204729 hasConceptScore W2368204729C2776232574 @default.
- W2368204729 hasConceptScore W2368204729C2776694085 @default.
- W2368204729 hasConceptScore W2368204729C2776715498 @default.
- W2368204729 hasConceptScore W2368204729C2776755627 @default.
- W2368204729 hasConceptScore W2368204729C2778119113 @default.
- W2368204729 hasConceptScore W2368204729C2778336483 @default.
- W2368204729 hasConceptScore W2368204729C2778476748 @default.
- W2368204729 hasConceptScore W2368204729C2779338263 @default.
- W2368204729 hasConceptScore W2368204729C2779429289 @default.
- W2368204729 hasConceptScore W2368204729C2779725641 @default.
- W2368204729 hasConceptScore W2368204729C2781413609 @default.
- W2368204729 hasConceptScore W2368204729C3019864225 @default.
- W2368204729 hasConceptScore W2368204729C71924100 @default.
- W2368204729 hasConceptScore W2368204729C90924648 @default.
- W2368204729 hasIssue "1" @default.
- W2368204729 hasLocation W23682047291 @default.
- W2368204729 hasOpenAccess W2368204729 @default.
- W2368204729 hasPrimaryLocation W23682047291 @default.
- W2368204729 hasRelatedWork W1870461427 @default.
- W2368204729 hasRelatedWork W1930245694 @default.
- W2368204729 hasRelatedWork W1972822547 @default.
- W2368204729 hasRelatedWork W1973686872 @default.
- W2368204729 hasRelatedWork W1999202698 @default.
- W2368204729 hasRelatedWork W2027596027 @default.
- W2368204729 hasRelatedWork W2035678502 @default.
- W2368204729 hasRelatedWork W2095254591 @default.
- W2368204729 hasRelatedWork W2183352065 @default.
- W2368204729 hasRelatedWork W2200643518 @default.
- W2368204729 hasRelatedWork W2281431331 @default.
- W2368204729 hasRelatedWork W2347623693 @default.
- W2368204729 hasRelatedWork W2347867967 @default.
- W2368204729 hasRelatedWork W2357852444 @default.
- W2368204729 hasRelatedWork W2361978760 @default.
- W2368204729 hasRelatedWork W2364745360 @default.
- W2368204729 hasRelatedWork W2372594420 @default.
- W2368204729 hasRelatedWork W2387327279 @default.
- W2368204729 hasRelatedWork W2417821789 @default.
- W2368204729 hasRelatedWork W2588498504 @default.
- W2368204729 hasVolume "39" @default.
- W2368204729 isParatext "false" @default.
- W2368204729 isRetracted "false" @default.
- W2368204729 magId "2368204729" @default.
- W2368204729 workType "article" @default.